Frazier Life Sciences
Overview
Frazier Life Sciences is a venture capital firm specializing in investments in private and publicly traded companies that discover, develop, and commercialize innovative biopharmaceuticals. The firm manages over $3.9 billion in capital, including venture funds focusing on company creation and private companies, and a public fund focused on small and mid-cap public companies. Since 2005, over 60 Frazier Life Sciences portfolio companies, many of which were created or seeded by FLS, have completed IPOs or M&As. The Frazier Life Sciences team consists of over 40 professionals with deep expertise in biopharmaceuticals, primarily located in Menlo Park, California (headquarters), San Diego, Seattle, Boston, New York, and London. Frazier Life Sciences invests globally in private and publicly traded companies that discover, develop, and commercialize innovative biopharmaceuticals. The firm has raised over $3.9 billion in capital, including venture funds focusing on company creation and private companies, and a public fund focused on small and mid-cap public companies. Since 2005, over 60 Frazier Life Sciences portfolio companies, many of which were created or seeded by FLS, have completed IPOs or M&As. The Frazier Life Sciences team consists of over 40 professionals with deep expertise in biopharmaceuticals, primarily located in Menlo Park, California (headquarters), San Diego, Seattle, Boston, New York, and London. Frazier Life Sciences invests globally in private and publicly traded companies that discover, develop, and commercialize innovative biopharmaceuticals. The firm has raised over $3.9 billion in capital, including venture funds focusing on company creation and private companies, and a public fund focused on small and mid-cap public companies. Since 2005, over 60 Frazier Life Sciences portfolio companies, many of which were created or seeded by FLS, have completed IPOs or M&As. The Frazier Life Sciences team consists of over 40 professionals with deep expertise in biopharmaceuticals, primarily located in Menlo Park, California (headquarters), San Diego, Seattle, Boston, New York, and London.
Investment Focus
- Innovative biopharmaceutical companies addressing significant medical needs
- Strong management teams
- Potential for substantial growth and value creation
Portfolio Companies
Reach Frazier Life Sciences directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Frazier Life Sciences
What sectors does Frazier Life Sciences invest in?
Frazier Life Sciences invests in Healthcare, Digital Health, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Washington, United States. Frazier Life Sciences is listed as a venture capital in the ConnectSafely investor database.
What stage does Frazier Life Sciences invest at?
Frazier Life Sciences backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 5M - 50M.
Which regions does Frazier Life Sciences invest in?
Frazier Life Sciences invests across United States, United Kingdom, Canada, Germany, Japan and Australia.
What companies has Frazier Life Sciences invested in?
Frazier Life Sciences's portfolio includes Mirum Pharmaceuticals, Syndax Pharmaceuticals, Phathom Pharmaceuticals, BridgeBio Pharma, Amunix Pharmaceuticals, Alpine Immune Sciences, Arcutis Biotherapeutics and NewAmsterdam Pharma.
Last updated · Source: ConnectSafely investor database
